Search

Author/Creator Putz, Eva M.

1. High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma. (1st February 2023)

Authors:
Grissenberger, Sarah; Sturtzel, Caterina; Wenninger-Weinzierl, Andrea; Radic-Sarikas, Branka; Scheuringer, Eva; Bierbaumer, Lisa; Etienne, Vesnie; Némati, Fariba; Pascoal, Susana; Tötzl, Marcus; Tomazou, Eleni M.; Metzelder, Martin; Putz, Eva M.; Decaudin, Didier; Delattre, Olivier; Surdez, Didie...
Journal:
Cancer letters
Issue:
Volume 554(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study. (January 2022)

Authors:
Fuereder, Thorsten; Minichsdorfer, Christoph; Mittlboeck, Martina; Wagner, Christina; Heller, Gerwin; Putz, Eva M.; Oberndorfer, Felicitas; Müllauer, Leonhard; Aretin, Marie-Bernadette; Czerny, Christian; Schwarz-Nemec, Ursula
Journal:
Oral oncology
Issue:
Volume 124(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis. (1st February 2017)

Authors:
Putz, Eva M.; Guillerey, Camille; Kos, Kevin; Stannard, Kimberley; Miles, Kim; Delconte, Rebecca B.; Takeda, Kazuyoshi; Nicholson, Sandra E.; Huntington, Nicholas D.; Smyth, Mark J.
Journal:
Oncoimmunology
Issue:
Volume 6:Number 2(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search